nach oben

Diabetologia

Erschienen in:

01.01.2013 | Article

The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study

verfasst von: The InterAct Consortium

Erschienen in: Diabetologia | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Although a family history of type 2 diabetes is a strong risk factor for the disease, the factors mediating this excess risk are poorly understood. In the InterAct case-cohort study, we investigated the association between a family history of diabetes among different family members and the incidence of type 2 diabetes, as well as the extent to which genetic, anthropometric and lifestyle risk factors mediated this association.

Methods

A total of 13,869 individuals (including 6,168 incident cases of type 2 diabetes) had family history data available, and 6,887 individuals had complete data on all mediators. Country-specific Prentice-weighted Cox models were fitted within country, and HRs were combined using random effects meta-analysis. Lifestyle and anthropometric measurements were performed at baseline, and a genetic risk score comprising 35 polymorphisms associated with type 2 diabetes was created.

Results

A family history of type 2 diabetes was associated with a higher incidence of the condition (HR 2.72, 95% CI 2.48, 2.99). Adjustment for established risk factors including BMI and waist circumference only modestly attenuated this association (HR 2.44, 95% CI 2.03, 2.95); the genetic score alone explained only 2% of the family history-associated risk of type 2 diabetes. The greatest risk of type 2 diabetes was observed in those with a biparental history of type 2 diabetes (HR 5.14, 95% CI 3.74, 7.07) and those whose parents had been diagnosed with diabetes at a younger age (<50 years; HR 4.69, 95% CI 3.35, 6.58), an effect largely confined to a maternal family history.

Conclusions/interpretation

Prominent lifestyle, anthropometric and genetic risk factors explained only a marginal proportion of the excess risk associated with family history, highlighting the fact that family history remains a strong, independent and easily assessed risk factor for type 2 diabetes. Discovering factors that will explain the association of family history with type 2 diabetes risk will provide important insight into the aetiology of type 2 diabetes.

Nur mit Berechtigung zugänglich

Groop L, Forsblom C, Lehtovirta M et al (1996) Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585–1593PubMedCrossRef

Meigs JB, Cupples LA, Wilson PW (2000) Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 49:2201–2207PubMedCrossRef

van 't Riet E, Dekker JM, Sun Q, Nijpels G, Hu FB, van Dam RM (2010) Role of adiposity and lifestyle in the relationship between family history of diabetes and 20-year incidence of type 2 diabetes in U.S. women. Diabetes Care 33:763–767CrossRef

Harrison TA, Hindorff LA, Kim H et al (2003) Family history of diabetes as a potential public health tool. Am J Prev Med 24:152–159PubMedCrossRef

Manson JE, Rimm EB, Stampfer MJ et al (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774–778PubMedCrossRef

Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF (2007) Effect of BMI on lifetime risk for diabetes in the US. Diabetes Care 30:1562–1566PubMedCrossRef

Carey VJ, Walters EE, Colditz GA et al (1997) Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 145:614–619PubMedCrossRef

Sargeant LA, Wareham NJ, Khaw KT (2000) Family history of diabetes identifies a group at increased risk for the metabolic consequences of obesity and physical inactivity in EPIC-Norfolk: a population-based study. The European Prospective Investigation into Cancer. Int J Obes Relat Metab Disord 24:1333–1339PubMedCrossRef

Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589PubMedCrossRef

10.

Meigs JB, Shrader P, Sullivan LM et al (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359:2208–2219PubMedCrossRef

11.

Talmud PJ, Hingorani AD, Cooper JA et al (2010) Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 340:b4838PubMedCrossRef

12.

Lyssenko V, Jonsson A, Almgren P et al (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359:2220–2232PubMedCrossRef

13.

Vassy JL, Shrader P, Jonsson A et al (2011) Association between parental history of diabetes and type 2 diabetes genetic risk scores in the PPP-Botnia and Framingham Offspring Studies. Diabetes Res Clin Pract 93:e76–e79PubMedCrossRef

14.

Langenberg C, Sharp S, Forouhi NG et al (2011) Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 54:2272–2282PubMedCrossRef

15.

Bingham S, Riboli E (2004) Diet and cancer—the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 4:206–215PubMedCrossRef

16.

Haftenberger M, Lahmann PH, Panico S et al (2002) Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5:1147–1162PubMedCrossRef

17.

InterAct Consortium (2012) Validity of a short questionnaire to assess physical activity in 10 European countries. Eur J Epidemiol 27:15–25CrossRef

18.

Romaguera D, Guevara M, Norat T et al (2011) Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project. Diabetes Care 34:1913–1918PubMedCrossRef

19.

Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645PubMedCrossRef

20.

Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336–1341PubMedCrossRef

21.

Yasuda K, Miyake K, Horikawa Y et al (2008) Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 40:1092–1097PubMedCrossRef

22.

Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105–116PubMedCrossRef

23.

Thompson S, Kaptoge S, White I, Wood A, Perry P, Danesh J (2010) Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. Int J Epidemiol 39:1345–1359PubMedCrossRef

24.

Smith-Warner SA, Spiegelman D, Ritz J et al (2006) Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 163:1053–1064PubMedCrossRef

25.

Lin DY, Fleming TR, de Gruttola V (1997) Estimating the proportion of treatment effect explained by a surrogate marker. Stat Med 16:1515–1527PubMedCrossRef

26.

VanderWeele TJ, Vansteelandt S (2010) Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol 172:1339–1348PubMedCrossRef

27.

Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172PubMedCrossRef

28.

Moore LL, Lombardi DA, White MJ, Campbell JL, Oliveria SA, Ellison RC (1991) Influence of parents' physical activity levels on activity levels of young children. J Pediatr 118:215–219PubMedCrossRef

29.

Elks CE, den Hoed M, Zhao JH et al (2012) Variability in the heritability of body mass index: a systematic review and meta-regression. Front Endocrinol (Lausanne) 3:29

30.

Khan A, Lasker SS, Chowdhury TA (2003) Are spouses of patients with type 2 diabetes at increased risk of developing diabetes? Diabetes Care 26:710–712PubMedCrossRef

31.

Hemminki K, Li X, Sundquist K, Sundquist J (2010) Familial risks for type 2 diabetes in Sweden. Diabetes Care 33:293–297PubMedCrossRef

32.

Carlborg O, Haley CS (2004) Epistasis: too often neglected in complex trait studies? Nat Rev Genet 5:618–625PubMedCrossRef

33.

Tripathy D, Lindholm E, Isomaa B, Saloranta C, Tuomi T, Groop L (2003) Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband. Am J Physiol Endocrinol Metab 285:E1297–E1303PubMed

34.

Franks PW, Looker HC, Kobes S et al (2006) Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring. Diabetes 55:460–465PubMedCrossRef

35.

Holemans K, Aerts L, van Assche FA (2003) Lifetime consequences of abnormal fetal pancreatic development. J Physiol 547:11–20PubMedCrossRef

36.

Fowden AL, Giussani DA, Forhead AJ (2005) Endocrine and metabolic programming during intrauterine development. Early Hum Dev 81:723–734PubMedCrossRef

37.

Barwell ND, Malkova D, Moran CN et al (2008) Exercise training has greater effects on insulin sensitivity in daughters of patients with type 2 diabetes than in women with no family history of diabetes. Diabetologia 51:1912–1919PubMedCrossRef

38.

Walter FM, Emery J (2005) 'Coming down the line'—patients' understanding of their family history of common chronic disease. Ann Fam Med 3:405–414PubMedCrossRef

39.

Chang MH, Valdez R, Ned RM et al (2011) Influence of familial risk on diabetes risk-reducing behaviors among U.S. adults without diabetes. Diabetes Care 34:2393–2399PubMedCrossRef

40.

Tuomi T (2005) Type 1 and type 2 diabetes: what do they have in common? Diabetes 54(Suppl 2):S40–S45PubMedCrossRef

Titel: The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study
verfasst von: The InterAct Consortium
Publikationsdatum: 01.01.2013
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 1/2013
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-012-2715-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Production and function of IL-12 in islets and beta cells

Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation

Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?

A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells

Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype